Haemonetics Corp Earnings

Haemonetics Corp’s revenue fell -2.75% since last year same period to $338.97Mn in the Q4 2025. On a quarterly growth basis, Haemonetics Corp has generated 3.56% jump in its revenue since last 3-months.

Haemonetics Corp’s net profit jumped 19.33% since last year same period to $44.74Mn in the Q4 2025. On a quarterly growth basis, Haemonetics Corp has generated 15.66% jump in its net profits since last 3-months.

Haemonetics Corp’s net profit margin jumped 22.7% since last year same period to 13.2% in the Q4 2025. On a quarterly growth basis, Haemonetics Corp has generated 11.68% jump in its net profit margins since last 3-months.

Haemonetics Corp’s earning per share (EPS) estimates for the current quarter stand at 1.27 - a 41.11% jump from last quarter’s estimates.

Haemonetics Corp’s earning per share (EPS) estimates for the current year stand at 1.27.

Haemonetics Corp’s earning per share (EPS) jumped 28.38% since last year same period to 0.95 in the Q4 2025. This indicates that the Haemonetics Corp has generated 28.38% annual rate of jump in its earning per share (EPS) in the last 4 quarters.